{"slug":"sam-chun-dang-pharm","name":"삼천당제약","name_en":"Sam Chun Dang Pharm.","ticker":"000250.KQ","updated_at":"2026-07-11T10:22:24.559+00:00","canonical":"https://valuechain.wiki/sam-chun-dang-pharm","kicker":"코스닥 대형주","kicker_en":"KOSDAQ large cap","lead":"점안제에 강점을 지닌 제약기업으로, 안과용 의약품과 바이오시밀러, 경구용 인슐린 개발을 추진한다. 코스닥 시가총액 상위 종목. 밸류체인 관계·수치 데이터는 조사 전인 기본 노드로, AI 질문 수요가 관측되면 상세 노드로 승격된다.","lead_en":"A pharma company strong in eye drops, pursuing ophthalmic medicines, biosimilars and oral insulin development. KOSDAQ large-cap constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.","segments":{"parts":[{"name":"점안제/전문의약품"},{"name":"바이오시밀러"},{"name":"경구용 인슐린"}]},"segments_en":{"parts":[{"name":"Eye drops/prescription drugs"},{"name":"Biosimilars"},{"name":"Oral insulin"}]},"returns_yearly":{"2021":-43,"2022":40,"2023":33.3,"2024":187.4,"2025":161.2,"2026":-58.5},"return_asof":"2026-07-10","value_chain":{"leading":[],"benefiting":[],"analysis":null,"analysis_en":null,"analysis_asof":null},"edges":[]}